About SINTX
SINTX is a company based in Salt Lake City (United States) founded in 1996.. SINTX has raised $122.4 million across 17 funding rounds from investors including NIH, HHS and Oxford Finance. The company has 20 employees as of December 31, 2024. SINTX has completed 1 acquisition, including Technology Assessment & Transfer. SINTX offers products and services including Silicon Nitride Industrial (STX-100), Silicon Nitride Biomedical (FleX-SN), and Composite 3D Printing. SINTX operates in a competitive market with competitors including RevBio, ParaGen Technologies, Avisi Technologies, Helicoid Industries and Dianomi Therapeutics, among others.
- Headquarter Salt Lake City, United States
- Employees 20 as on 31 Dec, 2024
- Stage Public
-
Sectors
Chemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sintx Technologies, Inc.
-
Annual Revenue
$2.89 M9.9as on Dec 31, 2024
-
Net Profit
$-11.02 M-33.48as on Dec 31, 2024
-
EBITDA
$-7.65 M34.59as on Dec 31, 2024
-
Total Equity Funding
$122.4 M (USD)
in 17 rounds
-
Latest Funding Round
$5 M (USD), Post-IPO
Feb 20, 2025
-
Investors
NIH
& 4 more
-
Employee Count
20
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SINTX
SINTX is a publicly listed company on the NASDAQ with ticker symbol SINT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SINTX
SINTX offers a comprehensive portfolio of products and services, including Silicon Nitride Industrial (STX-100), Silicon Nitride Biomedical (FleX-SN), and Composite 3D Printing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hard, corrosion-resistant ceramic for industrial and high-temperature applications.
Ceramic with antibacterial properties for medical implants and devices.
Service for transforming concepts into printed parts using advanced ceramics.
Funding Insights of SINTX
SINTX has successfully raised a total of $122.4M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 17
- Last Round Post-IPO — $5.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Post-IPO - SINTX | Valuation |
investors |
|
| Oct, 2023 | Amount | Grant - SINTX | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - SINTX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SINTX
SINTX has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SINTX
SINTX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Technology Assessment & Transfer. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of metal services
|
1983 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SINTX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sintx Comparisons
Competitors of SINTX
SINTX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RevBio, ParaGen Technologies, Avisi Technologies, Helicoid Industries and Dianomi Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Tissue engineering technologies are developed with synthetic nanofiber scaffolds.
|
|
| domain | founded_year | HQ Location |
Nano-materials for glaucoma treatment implants are developed.
|
|
| domain | founded_year | HQ Location |
Composite materials and components are produced using helicoid structures.
|
|
| domain | founded_year | HQ Location |
Therapies for inflammatory diseases are developed via MCM technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sintx
Frequently Asked Questions about SINTX
When was SINTX founded?
SINTX was founded in 1996 and raised its 1st funding round 7 years after it was founded.
Where is SINTX located?
SINTX is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Who is the current CEO of SINTX?
B. Sonny Bal is the current CEO of SINTX.
Is SINTX a funded company?
SINTX is a funded company, having raised a total of $122.4M across 17 funding rounds to date. The company's 1st funding round was a Grant of $227.14K, raised on Dec 01, 2003.
How many employees does SINTX have?
As of Dec 31, 2024, the latest employee count at SINTX is 20.
What is the annual revenue of SINTX?
Annual revenue of SINTX is $2.89M as on Dec 31, 2024.
What does SINTX do?
SINTX was founded in 1996 and is based in Salt Lake City, United States. Operations center on the medical devices sector, where interbody fusion devices are produced from medical-grade silicon nitride. Bone growth is facilitated by a nano surface texture, and the materials strength exceeds that of bone. Imaging capabilities and antibacterial properties are incorporated to address clinical requirements in spinal applications.
Who are the top competitors of SINTX?
SINTX's top competitors include RevBio, Avisi Technologies and ParaGen Technologies.
What products or services does SINTX offer?
SINTX offers Silicon Nitride Industrial (STX-100), Silicon Nitride Biomedical (FleX-SN), and Composite 3D Printing.
Is SINTX publicly traded?
Yes, SINTX is publicly traded on NASDAQ under the ticker symbol SINT.
How many acquisitions has SINTX made?
SINTX has made 1 acquisition, including Technology Assessment & Transfer.
Who are SINTX's investors?
SINTX has 5 investors. Key investors include NIH, HHS, Oxford Finance, Zions Bank, and Evermore Investments.
What is SINTX's ticker symbol?
The ticker symbol of SINTX is SINT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.